Amundi’s Vera Therapeutics VERA Stock Holding History

Amundi’s Portfolio VERA Stock Details VERA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-44	Closed	-$1K	–	2161
2025 Q1	$1K	Buy	44 +28	+175%	+$900	﹤0.01%	2038
2024 Q4	$675	Buy	+16	New	+$708	﹤0.01%	2072

Other funds holding VERA

ACA

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

KCM

Kynam Capital Management Princeton, New Jersey $1.62B AUM 138.67% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

VPC

Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Sofinnova Investments Menlo Park, California $2.63B AUM 117.41% 1-Year Est. Return

Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return

Amundi's VERA Position: Q2 2025 in Review

Amundi sold out of Vera Therapeutics (VERA) in Q2 2025, closing a stake of 44 shares — an estimated $1K sold.

Amundi first reported a position in VERA in Q4 2024 and held it in 2 quarters. The position peaked at $1K in Q1 2025. 172 funds tracked by Wall St. Rank hold VERA as of Q2 2025.

Amundi reported no remaining Vera Therapeutics position as of Q2 2025 after selling out during the quarter.
Amundi sold 44 Vera Therapeutics shares in Q2 2025, an estimated $1K.
Amundi first reported a position in Vera Therapeutics in Q4 2024 and held it in 2 quarters.
Amundi's Vera Therapeutics position peaked at $1K in Q1 2025.
172 funds tracked by Wall St. Rank held Vera Therapeutics as of Q2 2025.

Based on Amundi's 13F filing for Q2 2025, filed 13 Aug 2025.